Yahoo
NYSE American - BOATS Real Time Price USD

Picard Medical, Inc. (PMI)

6.83 +0.40 (+6.22%)
At close: October 27 at 4:00:00 PM EDT
6.42 -0.41 (-6.00%)
Overnight: 10:55:36 PM EDT
Chart Range Bar
Loading chart for PMI
Chart does not reflect overnight price.
  • Previous Close 6.43
  • Open 6.69
  • Bid 6.15 x 10000
  • Ask 6.84 x 10000
  • Day's Range 6.51 - 6.97
  • 52 Week Range 2.65 - 224.60
  • Volume 52,782
  • Avg. Volume 1,604,863
  • Market Cap (intraday) 15.973M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -6.93
  • Earnings Date (est.) Aug 14, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Zacks Rating Bullish

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

www.picardmedical.com

75

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 10/27/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PMI
92.19%
S&P 500 (^GSPC)
12.81%

1-Year Return

PMI
97.12%
S&P 500 (^GSPC)
12.33%

3-Year Return

PMI
96.76%
S&P 500 (^GSPC)
87.56%

5-Year Return

PMI
96.76%
S&P 500 (^GSPC)
69.66%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.95M
Earnings -5.66M
Profit Margin -191.60%

Q2

FY26

-4M
-2M
0
2M
-191.6%

Statistics

View More

Valuation Measures

Annual
As of 10/26/2026
  • Market Cap

    15.04M

  • Enterprise Value

    16.58M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    0.74

  • Price/Book (mrq)

    7.70

  • Enterprise Value/Revenue

    2.63

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -93.61%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.3M

  • Net Income Avi to Common (ttm)

    -26.42M

  • Diluted EPS (ttm)

    -6.93

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38k

  • Total Debt/Equity (mrq)

    91.96%

  • Levered Free Cash Flow (ttm)

    -22.79M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

6.83 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: